Provider review
Healthon review
One entry figure for a doctor-led plan, with neither molecule priced separately.
The figure is mid-range and visible up front. Nothing published says which molecule the program uses, or what happens above the starting point.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Healthon
From $189/mo, neither molecule priced separately
FDA warning letter · Healthon · September 2025 · addressed to Healthon Inc. dba Healthon. Details in our review.
- Vs median
- $20/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The entry figure is mid-range for this category and the program is described as doctor-led and personalized, with a broader longevity and skin catalog priced alongside it. What a reader cannot do here is any of the arithmetic this site exists to help with. The weight-loss figure is a starting point with nothing published about what it starts from — not a dose, not a plan length, not a molecule. Neither semaglutide nor tirzepatide is priced separately, so the two cannot be compared, and nothing on the page establishes which one a reader would actually receive or whether they get any choice in it. That combination is common enough in this category to be unremarkable, but it does mean the published number tells you roughly what the cheapest version of something costs without telling you what the something is. If the wider longevity catalog is part of the appeal, its pricing is presented the same way and is at least easier to compare against other sellers, because those products are more standardized than a personalized GLP-1 plan can be.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a mid-range entry figure visible before any intake.
- You want the plan described as doctor-led rather than automated.
- You are interested in the longevity and skin lines alongside weight loss.
Look elsewhere if
- You want to know which molecule you would receive. Nothing published says.
- You want to compare semaglutide against tirzepatide. Neither is priced separately.
- You need a ceiling. The figure is a starting point only.
What it actually costs
Price as published
A monthly weight-loss program with "prices start from $189/mo", described as personalized and doctor-led, with an aging and longevity line from $150/mo and further skin and wellness treatments priced alongside · every figure is a "start from", so the weight-loss entry point is a floor with no ceiling published and no dose behind it · neither molecule is priced separately, so semaglutide and tirzepatide cannot be compared here, and nothing published says which the program uses · the catalog is broad — weight loss, aging, skin, general wellness — with the GLP-1 line one part of it rather than the whole business
- Vs median
- $20/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. One "start from" figure covers the whole weight-loss program and neither molecule is priced separately, so nothing is readable per molecule before intake and nothing published says which one a reader receives. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The entry figure is mid-range and visible before any intake.
- The program is described as doctor-led and personalized rather than automated.
- A broader longevity and skin catalog is priced on the same site.
Pharmacy, labs and oversight
Healthon dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Healthon publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Healthon in September 2025. It is addressed to Healthon Inc. dba Healthon — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Healthon is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
The entry figure is mid-range for this category and the program is described as doctor-led and personalized, with a broader longevity and skin catalog priced alongside it. What a reader cannot do here is any of the arithmetic this site exists to help with. The weight-loss figure is a starting point with nothing published about what it starts from — not a dose, not a plan length, not a molecule. Neither semaglutide nor tirzepatide is priced separately, so the two cannot be compared, and nothing on the page establishes which one a reader would actually receive or whether they get a choice. That combination is common enough in this category to be unremarkable, but it does mean the published number tells you roughly what the cheapest version of something costs without telling you what the something is. If the wider longevity catalog is part of the appeal, the pricing there is presented the same way and is easier to compare against other sellers, because those products are more standardized than a personalized GLP-1 plan.
The honest cons
Every figure is a "start from" with no ceiling published.
- Neither molecule is priced separately, so the two cannot be compared.
- No dose is published, and nothing says which molecule the program uses.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Healthon is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#223 of 373
Ordered with the companies that pay us first, and Healthon is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.